Xintela AB (publ) (STO:XINT)
Sweden · Delayed Price · Currency is SEK 0.1760
+0.0005 (0.28%)
Oct 13, 2026, 11:45 AM CET
Xintela AB Market Cap
Xintela AB has a market cap or net worth of 151.58 million as of October 12, 2026. It is the 39,057th most valuable company in the world and the 544th biggest in Sweden. Its market cap has decreased by 55.96% in one year.
Market Cap
151.58M
Enterprise Value
172.75M
Revenue
3.03M
Global Rank
Country Rank
#544 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since March 22, 2016, Xintela AB's market cap has increased from 103.68M to 151.58M, an increase of 46.20%. That is a compound annual growth rate of 3.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 154.60M | -22.19% |
| Dec 30, 2025 | 198.68M | 5.85% |
| Dec 30, 2024 | 187.69M | 26.87% |
| Dec 29, 2023 | 147.94M | -1.74% |
| Dec 30, 2022 | 150.56M | -26.24% |
| Dec 30, 2021 | 204.12M | 2.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 255.75M |
| IRLAB Therapeutics AB | 253.70M |
| Elicera Therapeutics AB | 183.86M |
| Diamyd Medical AB | 151.88M |
| Simris Group AB (PUBL) | 150.50M |
| Abera Bioscience AB | 140.62M |
| NextCell Pharma AB | 127.91M |
| Initiator Pharma | 123.22M |